Free Trial

Jazz Pharmaceuticals (JAZZ) SEC Filings & 10K Form

Jazz Pharmaceuticals logo
$110.27 -2.21 (-1.96%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$110.37 +0.10 (+0.09%)
As of 07/11/2025 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Jazz Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/10/2025
6:57 AM
Jazz Pharmaceuticals (Filer)
Form DEFA14A
07/10/2025
6:53 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
1:56 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:18 PM
Jazz Pharmaceuticals (Filer)
Form ARS
06/04/2025
3:50 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:03 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
3:08 PM
Jazz Pharmaceuticals (Filer)
Form PRE 14A
05/13/2025
5:51 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
6:33 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
6:00 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:09 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/21/2025
3:14 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2025
7:26 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/10/2025
7:20 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/09/2025
3:18 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/07/2025
7:16 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/04/2025
8:13 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/03/2025
4:32 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:25 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/01/2025
3:32 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2025
7:35 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
03/21/2025
5:54 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T
03/12/2025
1:24 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:17 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:19 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
5:01 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
4:36 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
5:57 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:00 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:43 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:49 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:51 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:14 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
4:04 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
2:15 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:42 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-C
03/05/2025
3:50 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-C
03/05/2025
6:09 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
6:11 AM
Jazz Pharmaceuticals (Subject)
Form SC TO-C
03/03/2025
7:19 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
A new rule goes live in July — and the banks are quietly cashing in (Ad)

A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.

To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how
03/03/2025
7:22 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:35 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:24 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:29 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:13 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:18 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:21 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:44 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:43 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
7:05 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:56 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
6:34 AM
Jazz Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
4:41 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:55 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:58 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:43 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:46 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:50 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:40 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:22 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:43 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
5:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:05 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:20 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
4:02 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
5:06 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:44 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
4:55 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:32 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:00 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
2:19 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
10/16/2024
3:13 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
10:38 AM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
1:27 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:39 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:39 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:41 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:45 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:48 PM
Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:50 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:52 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
08/06/2024
3:53 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:57 PM
Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:29 PM
Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:35 PM
Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:42 PM
Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:49 PM
Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:55 PM
Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:19 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
6:33 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:JAZZ) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners